EU Asked to Include Microbial Proteins & Fermentation in Upcoming Biotech Act

Why It Matters

Including fermentation in Biotech Act II would unlock domestic production, reduce import reliance and strengthen the EU’s climate‑resilient bioeconomy.

Key Takeaways

• EU Biotech Act II may name fermentation as a covered technology.
• Europe imports ~70% of plant protein for animal feed, mainly soy.
• China supplies most fermentation-derived amino acids, creating geopolitical risk.
• €1.4 billion (€≈$1.5 b) could generate $120 billion annual EU output by 2040.
• Proposal calls for fast‑track permits and EU Investment Bank blended finance.

Pulse Analysis

The EU’s first Biotech Act left novel foods and microbial ingredients on the sidelines, prompting criticism from climate and food‑security advocates. As the bloc drafts Biotech Act II, the focus is shifting toward agricultural and industrial biotech, yet the legislation still lacks a clear category for advanced fermentation. By naming single‑cell proteins, mycelium and precision‑fermentation as covered technologies, the EU could create regulatory certainty that mirrors the fast‑moving sectors in the United States and Asia, encouraging firms to invest in domestic biomanufacturing facilities.

Europe’s current food supply chain is heavily exposed to external shocks. Roughly 70 % of the plant protein used in animal feed is imported, primarily soy from South America, while critical fermentation‑derived amino acids and vitamins come from China—a country that has already leveraged fertilizer export controls for geopolitical gain. A policy brief from WePlanet estimates that a €1.4 billion ($1.5 b) infusion into alternative‑protein production could generate €111 billion ($120 b) in annual economic output by 2040, underscoring the macro‑economic upside of reducing these dependencies. The EU’s €350 million ($378 million) life‑sciences funding signal shows growing political appetite, but scale‑up barriers remain largely financial and procedural.

To translate potential into reality, WePlanet recommends a suite of policy tools: fast‑track permitting, a single national point of contact for facility approvals, and a dedicated industrial fermentation investment pilot backed by the European Investment Bank. Blended‑finance instruments could de‑risk early‑stage projects, while shared pilot plants would lower entry costs for SMEs. If adopted, these measures would not only bolster food security and strategic autonomy but also position the EU as a competitive hub for microbial protein and precision‑fermentation innovation, driving jobs and sustainable growth across the continent.